Evidence map›Paper›PMID 34868053›Full record

ArticleFrontiers in immunology2021

The PID Principles of Care: Where Are We Now? A Global Status Report Based on the PID Life Index.

Julia Nordin, Leire Solís, Johan Prévot, Nizar Mahlaoui, Helen Chapel, Silvia Sánchez-Ramón, Adli Ali, John W Seymour, Martine Pergent

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. fSCIG 10% in pediatric primary immunodeficiency diseases: a European post-authorization safety study.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Congenital Athymia: Unmet Needs and Practical Guidance.Therapeutics and clinical risk management · 2023
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 5 countries.

Julia NordinThe International Patient Organisation for Primary Immunodeficiencies, Downderry, United Kingdom.
Leire SolísThe International Patient Organisation for Primary Immunodeficiencies, Downderry, United Kingdom.
Johan PrévotThe International Patient Organisation for Primary Immunodeficiencies, Downderry, United Kingdom.
Nizar MahlaouiPediatric Immunology-Hematology and Rheumatology Unit, Necker Children's University Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
Helen ChapelNuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
Silvia Sánchez-RamónDepartment of Clinical Immunology, Instituto de Medicina del Laboratorio (IML) and Instituto de Investigación Clínico San Carlos (IdISSC), Hospital Clínico San Carlos, Madrid, Spain.
Adli AliClinical Immunology Unit, Department of Paediatrics, Faculty of Medicine, Universiti Kebangsaan Malaysia Medical Centre, Kuala Lumpur, Malaysia.
John W SeymourThe International Patient Organisation for Primary Immunodeficiencies, Downderry, United Kingdom.
Martine PergentThe International Patient Organisation for Primary Immunodeficiencies, Downderry, United Kingdom.
Centre de Référence Déficits Immunitaires Héréditaires · FRInstituto de Investigación Sanitaria del Hospital Clínico San Carlos · ESMinnesota State University, Mankato · USUniversity Kebangsaan Malaysia Medical Centre · MYUniversity of Oxford · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A global gold standard framework for primary immunodeficiency (PID) care, structured around six principles, was published in 2014. To measure the implementation status of these principles IPOPI developed the PID Life Index in 2020, an interactive tool aggregating national PID data. This development was combined with a revision of the principles to consider advances in the field of health and science as well as political developments since 2014. The revision resulted in the following six principles: PID diagnosis, treatments, universal health coverage, specialised centres, national patient organisations and registries for PIDs. A questionnaire corresponding to these principles was sent out to IPOPI's national member organisations and to countries in which IPOPI had medical contacts, and data was gathered from 60 countries. The data demonstrates that, regardless of global scientific progress on PIDs with a growing number of diagnostic tools and better treatment options becoming available, the accessibility and affordability of these remains uneven throughout the world. It is not only visible between regions, but also between countries within the same region. One of the most urgent needs is medical education. In countries without immunologists, patients with PID suffer the risk of remaining undiagnosed or misdiagnosed, resulting in health implications or even death. Many countries also lack the infrastructure needed to carry out more advanced diagnostic tests and perform treatments such as hematopoietic stem cell transplantation or gene therapy. The incapacity to secure appropriate diagnosis and treatments affects the PID environment negatively in these countries. Availability and affordability also remain key issues, as diagnosis and treatments require coverage/reimbursement to ensure that patients with PID can access them in practice, not only in theory. This is still not the case in many countries of the world according to the PID Life Index. Although some countries do perform better than others, to date no country has fully implemented the PID principles of care, confirming the long way ahead to ensure an optimal environment for patients with PID in every country.

Indexed as

Combined Modality TherapyDelivery of Health CareDisease ManagementDisease SusceptibilityGlobal HealthHumansInfant, NewbornInsurance CoverageInsurance, HealthMass ScreeningNeonatal ScreeningPopulation SurveillancePrimary Health CarePrimary Immunodeficiency DiseasesRegistriesStandard of Carediagnosisglobal PID dataPID patient organisationsprimary immunodeficiencyregistriesspecialised centrestreatmentuniversal health care

Identifiers

PMID34868053
PMCPMC8637458
OpenAlexW3217586878

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.